
1-(1-Naphthyl) piperazine (hydrochloride)ligand for 5-HT receptors |
Sample solution is provided at 25 µL, 10mM.
































Quality Control & MSDS
- View current batch:
- Purity = 98.00%
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure


1-(1-Naphthyl) piperazine (hydrochloride) Dilution Calculator
calculate

1-(1-Naphthyl) piperazine (hydrochloride) Molarity Calculator
calculate
Cas No. | 104113-71-5 | SDF | Download SDF |
Synonyms | 1-NP | ||
Chemical Name | 1-(1-naphthalenyl)-piperazine, monohydrochloride | ||
Canonical SMILES | C1(C(N2CCNCC2)=CC=C3)=C3C=CC=C1.Cl | ||
Formula | C14H16N2 • HCl | M.Wt | 248.7 |
Solubility | ≥13.7mg/mL in DMSO | Storage | Store at -20°C |
Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
1-(1-Naphthyl) piperazine (1-NP) is a serotonergic ligand which could bind nonselectively with multiple serotonin (5-HT) receptors [1].
The serotonin receptors, also known as 5-HT receptors, belong to a family of G protein-coupled receptors (GPCRs) and ligand-gated ion channels (LGICs) found in the central and peripheral nervous systems. The serotonin receptors have been involved in many biological and neurological processes, such as aggression, anxiety, cognition, learning, memory, and mood [2].
In vitro: 1-NP binds to human 5- HT6 (h5-HT6) serotonin receptors with a Ki of 120 nM [1]. In rat cortical membranes, 1-NP inhibited the activity of 5-HT1 and 5-HT2 with IC50 values of 6 and 1 nM, respectively. 1-NP also blocked contraction in the rat fundus induced by either 5-HT or tryptamine with an IC50 of 1 nM [3].
In vivo: In squirrel monkeys, 1-NP (0.3–1.0 mg/kg) blocked the decrease of responding under fixed-interval (FI) schedules of presentation of food caused by DOB (0.01–0.3 mg/kg), an agonist of 5-HT2. 1-NP also antagonized the decreases in responding produced by quipazine (0.1–5.6 mg/kg), another agonist with predominant 5-HT2 actions [4].
References:[1] Lee M, Rangisetty J B, Pullagurla M R, et al. 1-(1-Naphthyl) piperazine as a novel template for 5-HT 6 serotonin receptor ligands[J]. Bioorganic & medicinal chemistry letters, 2005, 15(6): 1707-1711.[2] Nichols D E, Nichols C D. Serotonin receptors[J]. Chemical reviews, 2008, 108(5): 1614-1641.[3] Cohen M L, Wittenauer L A. Relationship between serotonin and tryptamine receptors in the rat stomach fundus[J]. Journal of Pharmacology and Experimental Therapeutics, 1985, 233(1): 75-79.[4] McKearney J W. Serotonin-antagonist effects of 1-(1-naphthyl) piperazine on operant behavior of squirrel monkeys[J]. Neuropharmacology, 1989, 28(8): 817-821.
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
NaturalProteinStopsDeadlyHumanBrainCancerInMice
ScientistsfromJohnsHopkinsandfromtheUniversityofMilanhaveeffectivelyproventhattheycaninhibitlethalhumanbraincancersinmiceusingaproteinthatselectivelyinducespositivechangesintheactivityofcellsthatbehavelikecancerstemcells.ThereportispublishedinNature.
Themostcommontypeofbraincancer-glioblastoma-ismarkedbythepresenceofthesestem-cell-likebraincells,which,insteadoftriggeringthereplacementofdamagedcells,formcancertissue.Stemcells,unlikeallothercellsinthebody,arecapableofformingalmostanykindofcellwhentheright"signals"triggertheirdevelopment.
Fortheirtreatmentexperiment,theresearchersreliedonaclassofproteins,bonemorphogenicproteins,thatcauseneuralstem-cell-likeclusterstolosetheirstemcellproperties,whichinturnstopstheirABIlitytodivide.
Firsttheypretreatedhumanglioblastomacellswithbonemorphogenicprotein4(BMP4),theninjectedthesetreatedcellsintomousebrains.Inmiceinjectedwithcellsthatwerenotpretreated,large,invasivecancersgrew.InthemicewithBMP4-treatedcells,nocancersgrewatall.Threetofourmonthsafterinjection,allmicethatgotuntreatedcellsdied,andnearlyallmicewithBMP4-treatedcellswerealive.
Next,thescientistsdeliveredslow-releaseBMP4-containing"beads"directlyintomousebrainswithimplantedglioblastomacells.Micethatgotemptybeadsdevelopedlargemalignanttumorsanddied.MicewithBMP4beadssurvivedmuchlonger,and80percentsurvivedfourmonthsaftercancercellimplants.
"OurideaistotreatpatientswithBMP4orsomethinglikeitrightaftersurgerytoremoveglioblastomainhopesofpreventingtheregrowthofthecancerandimprovingsurvivaltime,"saysAlessandroOlivi,M.D.,directoroftheDivisionofNeurosurgicalOncologyatHopkinsandacontributortothestudy.
OlivisaysclinicalstudiesusingBMP4couldbeginwithinayearand,ifsuccessful,drugtherapiescouldbeavailabletothepublicwithinthreetofouryears.
"ThiswasproofoftheideathatBMPscouldstopglioblastomabydepletingthestem-cell-likepopulationthatfeedsit,"saysHenryBrem,M.D.,chairmanoftheDepartmentofNeurosurgeryatHopkinsandacollaboratorinthestudy."Thisopensexcitingdoorstofutureresearchintotreatmentsandtherapiesforsuchadevastatingdisease."

